GRI

GRI

USD

GRI Bio Inc. Common Stock

$1.680-0.080 (-4.545%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$1.760

Haut

$1.760

Bas

$1.600

Volume

0.06M

Fondamentaux de l'Entreprise

Capitalisation Boursière

4.2M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

1.17M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.1Actuel $1.680Haut $16.949

Actualités Connexes

Analyst Upgrades

Ascendiant Capital Maintains Buy on GRI Bio, Raises Price Target to $35

Ascendiant Capital analyst Edward Woo maintains GRI Bio with a Buy and raises the price target from $34 to $35.

Voir plus
Ascendiant Capital Maintains Buy on GRI Bio, Raises Price Target to $35
GlobeNewswire

GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF")

No decline in lung function observed at 6-week interim analysis builds upon positive safety and biomarker data Phase 2a study fully enrolled; Topline data on track for Q3 2025 Currently available treatments for IPF are

Voir plus
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF")